Next |
home / stock / enlv / enlv message board
Subject | By | Source | When |
---|---|---|---|
Fundamentals on this one are amazing | WolfKlaw | investorshub | 04/24/2021 4:28:44 AM |
Yeah, I call that all steak and no | Clemdane | investorshub | 04/23/2021 7:05:39 PM |
This company has so much potential upside I | WolfKlaw | investorshub | 04/09/2021 9:20:41 AM |
You as well! | Clemdane | investorshub | 04/06/2021 3:59:52 PM |
Best of luck to you | WolfKlaw | investorshub | 04/05/2021 12:21:15 PM |
I'm going to get some tomorrow finally | Clemdane | investorshub | 04/05/2021 12:21:24 AM |
I have added more on the weakness | WolfKlaw | investorshub | 04/04/2021 5:13:14 PM |
No, didn't have the funds till now actually. | Clemdane | investorshub | 04/04/2021 1:30:30 PM |
Did you ever get in? | WolfKlaw | investorshub | 04/04/2021 12:51:23 PM |
Hope to join you soon | Clemdane | investorshub | 02/14/2021 8:01:52 PM |
I added more this week | WolfKlaw | investorshub | 02/14/2021 1:55:19 PM |
Thanks for answering! This is looking really good. | Clemdane | investorshub | 02/13/2021 2:53:59 AM |
Closing of offering announced. http://www.globenewswire.com/news-release/2021 | EquityMonster83 | investorshub | 02/13/2021 2:20:26 AM |
Nice Ark added 23k ENLV. 411k shares now | EquityMonster83 | investorshub | 02/13/2021 1:39:17 AM |
Sepsis would be a $30b total addressable market, | EquityMonster83 | investorshub | 02/13/2021 1:35:30 AM |
No dont think so. | EquityMonster83 | investorshub | 02/13/2021 1:32:57 AM |
So I'm not too late? | Clemdane | investorshub | 02/12/2021 5:20:41 AM |
$ENLV Covid-19 Treatment. It works. $ENLV Covid-19 Treatment ?? | EquityMonster83 | investorshub | 02/12/2021 1:46:38 AM |
Great | WolfKlaw | investorshub | 02/11/2021 12:20:26 PM |
Nice. In big today around $20 | EquityMonster83 | investorshub | 02/11/2021 12:41:14 AM |
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NYSE Market:
Nes-Ziona, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Danish Medicines Agency (DKMA) authorized the expansion into Denmark of the Comp...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to...